Screener
TELA Bio TELA Q1 2026 earnings
Reported May 12, 2026 · After market close
Revenue$19.1MBeat by $462.3K
EPS-$0.21Miss by $0.07
Revenue estimate$18.6M
EPS estimate-$0.14
Next report
Nov 12, 2026 (In 4 weeks)Revenue estimate$20.0M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
FAQ
- When did TELA Bio report Q1 2026 earnings?
- TELA Bio (TELA) reported Q1 2026 earnings on May 12, 2026 after market close.
- What were TELA Bio's Q1 2026 revenue and EPS?
- TELA Bio reported revenue of $19.1M and eps of $-0.21 for Q1 2026.
- Did TELA Bio beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $18.6M by $462.3K. EPS missed the consensus estimate of $-0.14 by $0.07.
- How did TELA Bio's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 2.9% from $18.5M a year earlier and eps grew 16.0% from $-0.25.
- Where can I find TELA Bio's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-059393) and the 10-Q periodic report (0001104659-26-060234) directly on SEC EDGAR. The filing index links above go to sec.gov.
